Pfs Partners, LLC Merck & Co., Inc. Transaction History

Pfs Partners, LLC

$177 Billion
Q3 2024

A detailed history of Pfs Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pfs Partners, LLC holds 3,663 shares of MRK stock, worth $359,157. This represents 0.24% of its overall portfolio holdings.

Number of Shares

3,663

Previous 3,641 0.6%

Holding current value

$359,157

Previous $451 Million 7.72%

% of portfolio

0.24%

Previous 0.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$111.15 - $128.97 $2,445 - $2,837	22 Added 0.6%	3,663 $416 Million
Q2 2024 Jul 25, 2024	BUY	$123.8 - $132.96 $1,114 - $1,196	9 Added 0.25%	3,641 $451 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $1,925 - $2,243	17 Added 0.47%	3,632 $479 Million
Q4 2023 Jan 26, 2024	BUY	$100.18 - $109.02 $43,778 - $47,641	437 Added 13.75%	3,615 $394 Million
Q3 2023 Nov 30, 2023	BUY	$102.95 - $114.33 $1,956 - $2,172	19 Added 0.6%	3,178 $327 Million
Q2 2023 Nov 30, 2023	BUY	$108.61 - $118.38 $2,063 - $2,249	19 Added 0.61%	3,159 $365 Million
Q1 2023 Nov 30, 2023	BUY	$102.94 - $114.86 $9,573 - $10,681	93 Added 3.05%	3,140 $334 Million
Q4 2022 Nov 30, 2023	BUY	$87.44 - $112.11 $1,923 - $2,466	22 Added 0.73%	3,047 $338 Million
Q3 2022 Nov 30, 2023	BUY	$84.53 - $94.96 $7,607 - $8,546	90 Added 3.07%	3,025 $261 Million
Q2 2022 Nov 30, 2023	BUY	$83.49 - $94.64 $1,836 - $2,082	22 Added 0.76%	2,935 $268 Million
Q1 2022 Nov 30, 2023	BUY	$73.51 - $82.4 $1,617 - $1,812	22 Added 0.76%	2,913 $239 Million
Q4 2021 Nov 30, 2023	BUY	$72.28 - $90.54 $208,961 - $261,751	2,891 New	2,891 $222 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfs Partners, LLC with notifications on news.

Account